The BBB damage observed in individuals with tauopathies without amyloid-β overproduction suggests a role for tau in BBB damage that is driven by chronic neuroinflammation initiated within the microglial compartment by extracellular tau aggregates (e-τ) released from injured neurons [151]. The gene discussed is MAPT; the disease is tauopathy.